Abstract:e20548 Background: To assess the therapeutic effect of compound pholcodine syrup and compound codeine phosphate oral solution on lung cancer cough. Methods: A total of 60 patients with diagnosed middle-advanced stage lung cancer accompanied with lung cancer cough from Jan, 2022 to May, 2022 were enrolled . According to the method of random number table, the patients were divided into two groups: observation group and control group. Observation group received compound pholcodine syrup treatment, while control group received compound codeine phosphate oral solution treatment. The dosage of the two drugs was 15 ml each time, 3 times a day, and the treatment course was 5 days. The antitussive effectiveness, cough severity and quality of life , were observed and compared between the two groups before and after the 3 days and 5 days treatment, respectively. Results: All 60 patients completed the treatment. Both two groups were effective in controlling lung cancer cough. After the 3 days treatment, the antitussive effective rates of the observation group and the control group were 83.3% (25/30) and 73.3% (22/30), respectively, with no statistical significance ( P= 0.347). After the 5 days treatment, the antitussive effective rates of observation group and control group were 90.0% (27/30) and 86.6% (26/30), respectively, with no statistical significance ( P= 0.687). There was no significant difference in the composition of patient cough severity between observation group[moderate and severe cough, 56.7% (17/30) ] and control group [moderate and severe cough, 67.7% (20/30) ]. After 3 days treatment, cough symptoms were relieved in both groups. Patients with mild cough accounted for 73.3% (22/30) in the observation group and 56.7% (17/30) in the control group, the difference was not statistically significant ( P= 0.331). What's more, after 5 dyas treatment, there was also no significant difference( P= 0.067)between observation group[mild cough, 86.7%(26/30)] and control group [mild cough, 66.7%(20/30)] . In the meantime, there were no significant differences in the physiological score, psychological score, social score and total score of the Leicester Cough Questionnaire in Mandarin-Chinese scale before the treatment, after 3 days and 5 days treatment between the two groups (all P > 0.05). Patients in the observation group had a lower incidence of xerostomia (0.0% vs 20.0 %, P= 0.024) and constipation (0.0% vs 20.0 %, P= 0.024) than control group. Conclusions: Compound pholcodine syrup and compound codeine phosphate oral solution are effective in treating lung cancer cough with similar antitussive effectiveness. Compound pholcodine syrup has a lower incidence of xerostomia and constipation than control group, which indicates that the security may be better. Clinical trial information: ChiCTR2300076684.

A Phase Ⅱ Clinical Trial for Compound Codeine Phosphate Tablets in Treatment of Moderate or Severe Cough

New Strategy for Cough Treatment-Comparison Effect and Safety of Cofetol Cough Syrup with Dextromethorphan Hydrobromide, Chorpheniramine Mateate and Pseudoe Phedrine Hydiochloride Solution in the Treatment of Acute Cough

Efficacy of compound pholcodine syrup and compound codeine phosphate oral solution on lung cancer cough.

Comparison Effect and Safety of Cofetol Cough Syrup with Compound Codeine Syrup in the Treatment of Infections of Respiratory Tract

Evaluation of Therapeutic Effect of Cofetol Cough Syrup in Comparison with Compound Codeine Syrup

Efficacy and Safety of Lubiprostone for the Treatment of Functional Constipation in Chinese Adult Patients: A Multicenter, Randomized, Double‐blind, Placebo‐controlled Trial

A multicenter study to evaluate the efficacy and safety of compound methoxyphenamine in the treatment of postinfectious cough

Efficacy and Safety of Dextromethorphan-Chlorpheniramine-pseudoephedrine Solution in Treating Cough Caused by Acute Upper Respiratory Tract Infections in 133 Patients

CLINICAL EVALUATION OF ANALGESIC EFFECT OF COMPOUND CODEINE PHOSPHATE TABLETS

Evaluation of clinical curative effect and safety of dimemorfan phosphate in the treatment of dry cough

Clinical Efficacy of Compound Methoxyphenamine Hydrochloride in the Treatment of Cough Variant Asthma

Rococo study: a real-world evaluation of an over-the-counter medicine in acute cough (a multicentre, randomised, controlled study)

A randomized, double-blinded, placebo-controlled clinical trial of duloxetine hydrochloride enteric-coated tablets in the treatment of refractory chronic cough

A Randomized, Controlled, Multicenter Clinical Trial To Evaluate The Efficacy And Safety Of Oral Sitafloxacin Versus Moxifloxacin In Adult Patients With Community-Acquired Pneumonia

Characterization of Codeine Treatment Responders Among Patients with Refractory or Unexplained Chronic Cough: A Prospective Real-World Cohort Study

A Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Lvpuweima Sustained-Release Tablet in the Treatment of Common Cold

Clinical Study on Procaterol in the Treatment of Children Persistent Cough: A Multicenter Randomized Controlled Study

Efficacy and Safety of Loratadine Paracetamol and Pseudoephedrine Sustained Release Tablets in the Treatment of Common Cold and Influenza

A RANDOMIZED AND DOUBLE- BLIND CONTROLLED CLINICAL TRIAL OF DIHYDROCODEINE TRATRATE FOR ANALGESIA

A multicenter,randomized,double blind,and controlled clinical trial of serrapeptase enteric-coated tablets as an expectorant

A Multicenter Randomized Double Blind Parallel Control Clinical Trial for Amoxicillin and Clavulanate Potassium Chewable Tablet in the Treatment of Acute Bacterial Infections